Difference between revisions of "Levine RL, et al. Cancer Cell (2005) cited as Ref 316 in DOI: 10.1038/s41392-020-0110-5 (Q9579)"
Jump to navigation
Jump to search
(Created claim: PubMed ID (P140): 15837627, #quickstatements; #temporary_batch_1590001671040) |
(Created claim: Page(s) (P105): 387-397, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (4 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2005
| ||||||||||||||
| Property / Publication Date: 2005 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Cancer Cell | ||||||||||||||
| Property / Published In Name String: Cancer Cell / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 7 | ||||||||||||||
| Property / Volume: 7 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera essential thrombocythemia and myeloid metaplasia with myelofibrosis (English) | ||||||||||||||
| Property / title: Activating mutation in the tyrosine kinase JAK2 in polycythemia vera essential thrombocythemia and myeloid metaplasia with myelofibrosis (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 387-397 | ||||||||||||||
| Property / Page(s): 387-397 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:37, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Levine RL, et al. Cancer Cell (2005) cited as Ref 316 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Levine RL
0 references
2005
0 references
Cancer Cell
0 references
7
0 references
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera essential thrombocythemia and myeloid metaplasia with myelofibrosis (English)
0 references
387-397
0 references
